These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 20645530

  • 1. Effects of ustekinumab administration on primate/human antigen-recall and humoral immune response functions.
    Brodmerkel C, Zhu Y, Jiao Q, Cornacoff J, Treacy G, Mascelli MA, Gottlieb AB.
    J Drugs Dermatol; 2010 Jun; 9(6):677-83. PubMed ID: 20645530
    [Abstract] [Full Text] [Related]

  • 2. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
    Bingham CO, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, Trzaskoma B, Martin F, Agarwal S, Kelman A.
    Arthritis Rheum; 2010 Jan; 62(1):64-74. PubMed ID: 20039397
    [Abstract] [Full Text] [Related]

  • 3. Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.
    Brodmerkel C, Wadman E, Langley RG, Papp KA, Bourcier M, Poulin Y, Ho V, Guenther L, Kunynetz R, Nigen S, Vender R, Wasel N, Hsu MC, Szapary P.
    J Drugs Dermatol; 2013 Oct; 12(10):1122-9. PubMed ID: 24085047
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12/23p40 monoclonal antibody, during pregnancy and lactation.
    Martin PL, Sachs C, Imai N, Tsusaki H, Oneda S, Jiao Q, Treacy G.
    Birth Defects Res B Dev Reprod Toxicol; 2010 Oct; 89(5):351-63. PubMed ID: 20540088
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial.
    Chatham WW, Wallace DJ, Stohl W, Latinis KM, Manzi S, McCune WJ, Tegzová D, McKay JD, Avila-Armengol HE, Utset TO, Zhong ZJ, Hough DR, Freimuth WW, Migone TS, BLISS-76 Study Group.
    J Rheumatol; 2012 Aug; 39(8):1632-40. PubMed ID: 22707609
    [Abstract] [Full Text] [Related]

  • 9. Pharmacodynamic effects of steady-state fingolimod on antibody response in healthy volunteers: a 4-week, randomized, placebo-controlled, parallel-group, multiple-dose study.
    Boulton C, Meiser K, David OJ, Schmouder R.
    J Clin Pharmacol; 2012 Dec; 52(12):1879-90. PubMed ID: 22174429
    [Abstract] [Full Text] [Related]

  • 10. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response.
    Bliss J, Van Cleave V, Murray K, Wiencis A, Ketchum M, Maylor R, Haire T, Resmini C, Abbas AK, Wolf SF.
    J Immunol; 1996 Feb 01; 156(3):887-94. PubMed ID: 8558014
    [Abstract] [Full Text] [Related]

  • 15. CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study.
    Shock A, Burkly L, Wakefield I, Peters C, Garber E, Ferrant J, Taylor FR, Su L, Hsu YM, Hutto D, Amirkhosravi A, Meyer T, Francis J, Malcolm S, Robinson M, Brown D, Shaw S, Foulkes R, Lawson A, Harari O, Bourne T, Maloney A, Weir N.
    Arthritis Res Ther; 2015 Sep 03; 17(1):234. PubMed ID: 26335795
    [Abstract] [Full Text] [Related]

  • 16. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.
    Kaine JL, Kivitz AJ, Birbara C, Luo AY.
    J Rheumatol; 2007 Feb 03; 34(2):272-9. PubMed ID: 17304653
    [Abstract] [Full Text] [Related]

  • 17. Beraprost enhances production of antigen-specific IgG isotypes without modulating germinal center B cell generation and the affinity maturation.
    Lee E, Kim J, Kim YM, Ha KS, Jeoung DI, Sin JI, Choe J.
    Int Immunopharmacol; 2013 Apr 03; 15(4):735-42. PubMed ID: 23499642
    [Abstract] [Full Text] [Related]

  • 18. Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trials.
    Gordon KB, Papp KA, Langley RG, Ho V, Kimball AB, Guzzo C, Yeilding N, Szapary PO, Fakharzadeh S, Li S, Hsu MC, Reich K.
    J Am Acad Dermatol; 2012 May 03; 66(5):742-51. PubMed ID: 21978572
    [Abstract] [Full Text] [Related]

  • 19. Hapten-induced primary and memory humoral responses are inhibited by the infusion of anti-CD20 monoclonal antibody (IDEC-C2B8, Rituximab).
    Gonzalez-Stawinski GV, Yu PB, Love SD, Parker W, Davis RD.
    Clin Immunol; 2001 Feb 03; 98(2):175-9. PubMed ID: 11161973
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.